Know Cancer

or
forgot password

Breast MRI Spectroscopy


N/A
N/A
N/A
Open (Enrolling)
Female
Suspicion of, or Known Breast Cancer

Thank you

Trial Information

Breast MRI Spectroscopy


Our aim is to perform MR Spectroscopy (MRS) on 150 evaluable patients at the end of their
routine breast MRI examination using a software package from General Electric Medical
Systems Milwaukee, WI). This will add time to the routine examination but will not involve
additional injections of contrast. We will analyze the spectroscopic data to determine if
benign lesions can be reliably differentiated from malignant ones.


Inclusion Criteria:



- Scheduled for diagnostic breast MRI examination or interventional procedure for a
known or suspected breast lesion

Exclusion Criteria:

- Patients who would be normally excluded from undergoing an MRI examination:

- Patients with a pacemaker, aneurysm clip or any other condition that would
warrant avoidance of a strong magnetic field

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

To determine if spectroscopy of the breast can be performed and can be functional in a clinical environment.

Outcome Time Frame:

12 months

Safety Issue:

No

Principal Investigator

Sandra Brennan, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

03-037

NCT ID:

NCT00577915

Start Date:

May 2003

Completion Date:

December 2013

Related Keywords:

  • Suspicion of, or Known Breast Cancer
  • Breast cancer
  • MRI spectroscopy
  • Diagnostic radiology
  • Breast Neoplasms

Name

Location

Memorial Sloan Kettering Cancer CenterNew York, New York  10021